SCHEMBL2397608

SCHEMBL2397608

CCOC(=O)C1=C(C)N=c2sc(=Cc3cc(Cl)c(OCC(=O)O)c(OC)c3)c(=O)n2C1c1ccccc1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN7 P35236 6/20 1.00
DUSP3 P51452 6/20 1.00
PTPN22 Q9Y2R2 4/20 1.00
PTPN12 Q05209 3/20 1.00
DUSP6 Q16828 2/20 0.91
MEN1 O00255 9/20 0.72
KMT2A Q03164 9/20 0.72
CTDSP1 Q9GZU7 2/20 0.69
BLM P54132 2/20 0.67
DNMT1 P26358 2/20 0.66
PSMD14 O00487 1/20 0.66
ALDH1A1 P00352 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
POLB P06746 1/20 0.60
CACNA1B Q00975 1/20 0.60
APBA1 Q02410 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
HTT P42858 1/20 0.60
LMNA P02545 1/20 0.59
MAPT P10636 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2398377 1.00 PTPN7 (1.00) PTPN7DUSP3PTPN22PTPN12DUSP6
SCHEMBL12267452 0.94 PTPN7 (0.90) PTPN7DUSP3PTPN22PTPN12DUSP6
SCHEMBL2397611 0.90 PTPN7 (0.82) PTPN7DUSP3PTPN22PTPN12DUSP6
SCHEMBL13855965 0.82 ALDH1A1 (0.76) PTPN7DUSP3PTPN22PTPN12DUSP6
SCHEMBL4669327 0.79 MEN1 (0.69) PTPN7DUSP3PTPN22PTPN12DUSP6
SCHEMBL4669325 0.79 MEN1 (0.69) PTPN7DUSP3PTPN22PTPN12DUSP6
SCHEMBL13855903 0.79 DUSP3 (0.65) PTPN7DUSP3PTPN22PTPN12DUSP6
SCHEMBL4670263 0.77 ALDH1A1 (0.84) PTPN7DUSP3PTPN22DUSP6MEN1
SCHEMBL4670262 0.77 ALDH1A1 (0.84) PTPN7DUSP3PTPN22DUSP6MEN1
SCHEMBL4669021 0.75 MEN1 (1.00) PTPN7DUSP3PTPN22PTPN12DUSP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212974-A1 METHOD FOR IDENTIFYING COMPOUNDS USEFUL FOR TREATING AND/OR PREVENTING DISEASE-ASSOCIATED BONE LOSS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) 2011-09-01 US claimed
EP-2716285-B9 Compounds for treating and/or preventing diseases associated with bone loss CENTRE NAT DE LA RECH SCIENT -CNRS- (FR) 2017-03-01 EP disclosed
EP-2716285-B1 Compounds for treating and/or preventing diseases associated with bone loss CENTRE NAT RECH SCIENT (FR) 2016-04-27 EP disclosed
EP-2331967-B1 NEW METHOD FOR IDENTIFYING COMPOUNDS USEFUL FOR TREATING AND/OR PREVENTING DISEASES ASSOCIATED WITH BONE LOSS CENTRE NAT RECH SCIENT (FR) 2015-11-04 EP disclosed
US-9091678-B2 Method for identifying compounds useful for treating and/or preventing disease-associated bone loss CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2015-07-28 US disclosed
US-20110212974-A1 METHOD FOR IDENTIFYING COMPOUNDS USEFUL FOR TREATING AND/OR PREVENTING DISEASE-ASSOCIATED BONE LOSS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212974-A1 METHOD FOR IDENTIFYING COMPOUNDS USEFUL FOR TREATING AND/OR PREVENTING DISEASE-ASSOCIATED BONE LOSS DOCK5, ARHGDIB, ARHGDIA PTPN7 3264/4885DUSP3 611/4885PTPN22 3222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.